Positive Peers App for HIV
(PoPIT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Positive Peers treatment for HIV?
Is the Positive Peers App safe for use in humans?
How is the Positive Peers App treatment different from other HIV treatments?
What is the purpose of this trial?
The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV.Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are associated with a) viral suppression, b) retention in care, and c) perceived HIV-related stigma?Participants will:* download the mobile app onto their personal smartphone* Use the mobile app as they find useful* complete online surveys at enrollment, 3 mo, 6, mo, 9 mo and 12 months.
Research Team
Ann Avery, MD
Principal Investigator
MetroHealth/ CWRU
Mary Step, PhD
Principal Investigator
Kent State University
Eligibility Criteria
This trial is for young people aged 13-34 with HIV, particularly from minority groups. Participants need to have a personal smartphone to download and use the Positive Peers mobile app and be willing to complete online surveys over a year at specified intervals.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Enrollment and Baseline
Participants complete a baseline survey and download the Positive Peers app
Immediate Start Intervention
Participants in the immediate start arm begin using the Positive Peers app
Delayed Start Intervention
Participants in the delayed start arm begin using the Positive Peers app after a 6-month delay
Follow-up
Participants are monitored for viral suppression and retention in care
Treatment Details
Interventions
- Positive Peers
Positive Peers is already approved in United States for the following indications:
- Support for HIV care and management among young adults (13-34 years old)
Find a Clinic Near You
Who Is Running the Clinical Trial?
MetroHealth Medical Center
Lead Sponsor
Kent State University
Collaborator